$AGN Company News Actavis expects profit to be
Post# of 144492
Posted On: 02/03/2015 9:39:10 AM
$AGN Company News
Actavis expects profit to beat expectations 9:44 a.m. Jan. 12, 2015 - Michael Calia
Drug trials, upgrades boost health-care sector 11:57 a.m. Jan. 8, 2015 - Russ Britt
Linn Energy jumps as Tesla, Apple fall 2:30 p.m. Jan. 2, 2015 - Wallace Witkowski
Eight charts plot the year in finance 12:45 p.m. Dec. 30, 2014 - Ophir Gottlieb
Here are the best S&P 500 stocks and sectors of 2014 1:52 p.m. Dec. 29, 2014 - Philip van Doorn
2014 was the year that all predictions were wrong 11:29 a.m. Dec. 26, 2014 - Marek Fuchs
What a week: Botox haze, merger Monday and The Tanned One 9:19 a.m. Nov. 21, 2014 - Marek Fuchs
Valeant's stock rises after new $2 billion buyback plan announced 12:00 p.m. Nov. 20, 2014 - Tomi Kilgore
La-Z-Boy shares rally after earnings beat targets 4:41 p.m. Nov. 18, 2014 - Sue Chang
Actavis shares outpace buyout target’s gains 12:30 p.m. Nov. 18, 2014 - Russ Britt
S&P 500 registers 42nd record close in skittish market 4:59 p.m. Nov. 17, 2014 - Carla Mozee
Urban Outfitters slides after earnings miss expectations 4:43 p.m. Nov. 17, 2014 - Sue Chang
Valeant says it won’t meet Actavis’s offer 12:18 p.m. Nov. 17, 2014 - Russ Britt
If you're looking big pharma, look no further than Actavis 11:33 a.m. Nov. 17, 2014 - The Trading Deck
Newscast: It's Merger Mania Monday 9:57 a.m. Nov. 17, 2014 - MarketWatch
Actavis to buy Allergan in $66 billion deal 9:35 a.m. Nov. 17, 2014 - Jonathan D. Rockoff
Actavis confirms to buy Allergan in $66 billion deal 9:30 a.m. Nov. 17, 2014 - Ciara Linnane
Mon., Nov. 17: Pfizer Stock After Pre-Market Drop 9:24 a.m. Nov. 17, 2014 - MarketWatch
Actavis, Allergan close to a deal 8:33 a.m. Nov. 17, 2014 - Jonathan D. Rockoff
Allergan's stock jumps 4.2% premarket after report of potential merger deal 8:22 a.m. Nov. 17, 2014 - Tomi Kilgore
What to Expect When Allergan (AGN) Reports Fourth-Quarter Earnings Tomorrow 3:38 p.m. Feb. 2, 2015 - TheStreet.com
Will Allergan (AGN) Disappoint on Earnings This Quarter? - Analyst Blog 3:20 p.m. Feb. 2, 2015 - Zacks.com
Revenge of the Giants in Stock Picks 5:03 a.m. Jan. 31, 2015 - Barrons.com
Judge Clears Way for Dendreon to Auction Provenge 2:32 p.m. Jan. 30, 2015 - The Wall Street Journal Interactive Edition
Valeant in Deal to Buy Provenge From Dendreon 10:39 p.m. Jan. 29, 2015 - The Wall Street Journal Interactive Edition
Sientra: A Breast Implant Pure-Play With A Technologically Superior Implant, Initiating Bullish 3:43 p.m. Jan. 29, 2015 - Seeking Alpha
Abbott Labs' (ABT) Q4 Earnings Up, Guides Below Estimates - Analyst Blog 11:23 a.m. Jan. 29, 2015 - Zacks.com
Roche Misses on Earnings in 2014, Beats on Revenues - Analyst Blog 8:27 a.m. Jan. 29, 2015 - Zacks.com
Actavis to Buy Auden Mckenzie, Boost Generic Portfolio - Analyst Blog 6:00 p.m. Jan. 27, 2015 - Zacks.com
3 Stocks Dragging The Health Care Sector Downward 12:07 p.m. Jan. 27, 2015 - TheStreet.com
A Radical Idea for Activist Investors 9:51 a.m. Jan. 27, 2015 - The Wall Street Journal Interactive Edition
Actavis to Buy Auden Mckenzie 8:15 a.m. Jan. 26, 2015 - The Wall Street Journal Interactive Edition
A Look At Actavis 2:31 p.m. Jan. 22, 2015 - Seeking Alpha
Trade-Ideas: Allergan (AGN) Is Today's New Lifetime High Stock 9:45 a.m. Jan. 22, 2015 - TheStreet.com
Jim Cramer Sees Actavis Shares Going Higher, Possibly to $320 11:40 a.m. Jan. 21, 2015 - TheStreet.com
The One Fund You Should Own in Your 401k 6:35 a.m. Jan. 21, 2015 - InvestorPlace.com
Salix Pharma Reportedly Exploring Sale; Stock Up 2:06 p.m. Jan. 20, 2015 - Investors Business Daily
Ackman Brings Veteran M&A Lawyer on Board 12:05 a.m. Jan. 20, 2015 - The Wall Street Journal Interactive Edition
New Activist Hedge Fund Has CEO Backing 12:00 a.m. Jan. 20, 2015 - The Wall Street Journal Interactive Edition
Roche to Acquire French Biotechnology Company Trophos - Analyst Blog 6:10 p.m. Jan. 19, 2015 - Zacks.com
Clinical Study: Improved Breast Reconstruction Outcomes with Seri Scaffold 7:01 p.m. Jan. 30, 2015 - PR Newswire - PRF
Global Pediatric Drugs and Vaccines Market 11:56 a.m. Jan. 27, 2015 - PR Newswire - PRF
Actavis Registration Statement for Pending Acquisition of Allergan Declared Effective by the SEC 5:30 p.m. Jan. 26, 2015 - BusinessWire - BZX
Actavis Registration Statement for Pending Acquisition of Allergan Declared Effective by the SEC 5:30 p.m. Jan. 26, 2015 - PR Newswire - PRF
Lieff Cabraser Announces Class Action Litigation Against Allergan Inc. - AGN 2:21 a.m. Jan. 23, 2015 - BusinessWire - BZX
UPDATE - AGN SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Involving Allergan, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of February 16, 2015 -- AGN 5:22 p.m. Jan. 20, 2015 - GlobeNewswire
Pre-Market Pulse on Pharma Stocks - Teva Pharma Industries, Allergan, Endo Intl., Akorn, and Depomed 8:30 a.m. Jan. 16, 2015 - PR Newswire - PRF
Actavis and Allergan Announce Early Termination of Hart-Scott-Rodino Waiting Period for Actavis’ Pending Acquisition of Allergan and Record Dates for Shareholder Meetings 8:02 a.m. Jan. 12, 2015 - BusinessWire - BZX
Actavis and Allergan Announce Early Termination of Hart-Scott-Rodino Waiting Period for Actavis' Pending Acquisition of Allergan and Record Dates for Shareholder Meetings 8:00 a.m. Jan. 12, 2015 - PR Newswire - PRF
ALERT: Rosen Law Firm Reminds Investors Who Sold Allergan Inc. Stock of the Important Class Action Deadline -- AGN 11:11 a.m. Jan. 6, 2015 - GlobeNewswire
Law Offices of Howard G. Smith Announces Investigation on Behalf of Investors Who Sold Allergan, Inc. Common Stock Between February 25, 2014 and April 21, 2014 10:32 a.m. Dec. 29, 2014 - BusinessWire - BZX
SHAREHOLDER ALERT: Investors Who Sold Allergan, Inc. Common Stock Between February 25, 2014 and April 21, 2014 Are Encouraged to Contact Glancy Binkow & Goldberg LLP 12:32 p.m. Dec. 23, 2014 - BusinessWire - BZX
AGN SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Involving Allergan, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of February 16, 2015 -- AGN 5:48 p.m. Dec. 18, 2014 - GlobeNewswire
EQUITY ALERT: The Rosen Law Firm Announces the Filing of Securities Class Action on Behalf of Sellers of Allergan Inc. Stock From February 25, 2014 to April 21, 2014 Seeking to Recover Losses -- AGN 3:59 p.m. Dec. 18, 2014 - GlobeNewswire
COTCHETT, PITRE & McCARTHY, LLP Files Class Action Lawsuit on Behalf of Persons Who Sold Allergan Stock Between February 25, 2014 and April 21, 2014 1:47 p.m. Dec. 17, 2014 - BusinessWire - BZX
Deadline in Lawsuit for Certain Sellers of Allergan, Inc. (AGN) Shares Announced by Shareholders Foundation 11:15 a.m. Dec. 17, 2014 - GlobeNewswire
BOTTINI & BOTTINI, INC. Files Class Action Lawsuit On Behalf Of Persons Who Sold Allergan Stock Between February 25, 2014 And April 21, 2014 9:30 a.m. Dec. 17, 2014 - PR Newswire - PRF
Pharma Equities Technical Analysis -- GlaxoSmithKline, Bristol-Myers Squibb, Teva Pharmaceutical Industries, Endo Intl., and Allergan 9:05 a.m. Dec. 17, 2014 - PR Newswire - PRF
Actavis Announces Proposed Senior Leadership Team Effective Following Completion of Allergan Acquisition 7:30 a.m. Dec. 16, 2014 - PR Newswire - PRF
Wilshire Confirms First-to-File Patent Challenge Relating to LASTACAFT® 3:18 p.m. Dec. 11, 2014 - PR Newswire - PRF
Actavis expects profit to beat expectations 9:44 a.m. Jan. 12, 2015 - Michael Calia
Drug trials, upgrades boost health-care sector 11:57 a.m. Jan. 8, 2015 - Russ Britt
Linn Energy jumps as Tesla, Apple fall 2:30 p.m. Jan. 2, 2015 - Wallace Witkowski
Eight charts plot the year in finance 12:45 p.m. Dec. 30, 2014 - Ophir Gottlieb
Here are the best S&P 500 stocks and sectors of 2014 1:52 p.m. Dec. 29, 2014 - Philip van Doorn
2014 was the year that all predictions were wrong 11:29 a.m. Dec. 26, 2014 - Marek Fuchs
What a week: Botox haze, merger Monday and The Tanned One 9:19 a.m. Nov. 21, 2014 - Marek Fuchs
Valeant's stock rises after new $2 billion buyback plan announced 12:00 p.m. Nov. 20, 2014 - Tomi Kilgore
La-Z-Boy shares rally after earnings beat targets 4:41 p.m. Nov. 18, 2014 - Sue Chang
Actavis shares outpace buyout target’s gains 12:30 p.m. Nov. 18, 2014 - Russ Britt
S&P 500 registers 42nd record close in skittish market 4:59 p.m. Nov. 17, 2014 - Carla Mozee
Urban Outfitters slides after earnings miss expectations 4:43 p.m. Nov. 17, 2014 - Sue Chang
Valeant says it won’t meet Actavis’s offer 12:18 p.m. Nov. 17, 2014 - Russ Britt
If you're looking big pharma, look no further than Actavis 11:33 a.m. Nov. 17, 2014 - The Trading Deck
Newscast: It's Merger Mania Monday 9:57 a.m. Nov. 17, 2014 - MarketWatch
Actavis to buy Allergan in $66 billion deal 9:35 a.m. Nov. 17, 2014 - Jonathan D. Rockoff
Actavis confirms to buy Allergan in $66 billion deal 9:30 a.m. Nov. 17, 2014 - Ciara Linnane
Mon., Nov. 17: Pfizer Stock After Pre-Market Drop 9:24 a.m. Nov. 17, 2014 - MarketWatch
Actavis, Allergan close to a deal 8:33 a.m. Nov. 17, 2014 - Jonathan D. Rockoff
Allergan's stock jumps 4.2% premarket after report of potential merger deal 8:22 a.m. Nov. 17, 2014 - Tomi Kilgore
What to Expect When Allergan (AGN) Reports Fourth-Quarter Earnings Tomorrow 3:38 p.m. Feb. 2, 2015 - TheStreet.com
Will Allergan (AGN) Disappoint on Earnings This Quarter? - Analyst Blog 3:20 p.m. Feb. 2, 2015 - Zacks.com
Revenge of the Giants in Stock Picks 5:03 a.m. Jan. 31, 2015 - Barrons.com
Judge Clears Way for Dendreon to Auction Provenge 2:32 p.m. Jan. 30, 2015 - The Wall Street Journal Interactive Edition
Valeant in Deal to Buy Provenge From Dendreon 10:39 p.m. Jan. 29, 2015 - The Wall Street Journal Interactive Edition
Sientra: A Breast Implant Pure-Play With A Technologically Superior Implant, Initiating Bullish 3:43 p.m. Jan. 29, 2015 - Seeking Alpha
Abbott Labs' (ABT) Q4 Earnings Up, Guides Below Estimates - Analyst Blog 11:23 a.m. Jan. 29, 2015 - Zacks.com
Roche Misses on Earnings in 2014, Beats on Revenues - Analyst Blog 8:27 a.m. Jan. 29, 2015 - Zacks.com
Actavis to Buy Auden Mckenzie, Boost Generic Portfolio - Analyst Blog 6:00 p.m. Jan. 27, 2015 - Zacks.com
3 Stocks Dragging The Health Care Sector Downward 12:07 p.m. Jan. 27, 2015 - TheStreet.com
A Radical Idea for Activist Investors 9:51 a.m. Jan. 27, 2015 - The Wall Street Journal Interactive Edition
Actavis to Buy Auden Mckenzie 8:15 a.m. Jan. 26, 2015 - The Wall Street Journal Interactive Edition
A Look At Actavis 2:31 p.m. Jan. 22, 2015 - Seeking Alpha
Trade-Ideas: Allergan (AGN) Is Today's New Lifetime High Stock 9:45 a.m. Jan. 22, 2015 - TheStreet.com
Jim Cramer Sees Actavis Shares Going Higher, Possibly to $320 11:40 a.m. Jan. 21, 2015 - TheStreet.com
The One Fund You Should Own in Your 401k 6:35 a.m. Jan. 21, 2015 - InvestorPlace.com
Salix Pharma Reportedly Exploring Sale; Stock Up 2:06 p.m. Jan. 20, 2015 - Investors Business Daily
Ackman Brings Veteran M&A Lawyer on Board 12:05 a.m. Jan. 20, 2015 - The Wall Street Journal Interactive Edition
New Activist Hedge Fund Has CEO Backing 12:00 a.m. Jan. 20, 2015 - The Wall Street Journal Interactive Edition
Roche to Acquire French Biotechnology Company Trophos - Analyst Blog 6:10 p.m. Jan. 19, 2015 - Zacks.com
Clinical Study: Improved Breast Reconstruction Outcomes with Seri Scaffold 7:01 p.m. Jan. 30, 2015 - PR Newswire - PRF
Global Pediatric Drugs and Vaccines Market 11:56 a.m. Jan. 27, 2015 - PR Newswire - PRF
Actavis Registration Statement for Pending Acquisition of Allergan Declared Effective by the SEC 5:30 p.m. Jan. 26, 2015 - BusinessWire - BZX
Actavis Registration Statement for Pending Acquisition of Allergan Declared Effective by the SEC 5:30 p.m. Jan. 26, 2015 - PR Newswire - PRF
Lieff Cabraser Announces Class Action Litigation Against Allergan Inc. - AGN 2:21 a.m. Jan. 23, 2015 - BusinessWire - BZX
UPDATE - AGN SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Involving Allergan, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of February 16, 2015 -- AGN 5:22 p.m. Jan. 20, 2015 - GlobeNewswire
Pre-Market Pulse on Pharma Stocks - Teva Pharma Industries, Allergan, Endo Intl., Akorn, and Depomed 8:30 a.m. Jan. 16, 2015 - PR Newswire - PRF
Actavis and Allergan Announce Early Termination of Hart-Scott-Rodino Waiting Period for Actavis’ Pending Acquisition of Allergan and Record Dates for Shareholder Meetings 8:02 a.m. Jan. 12, 2015 - BusinessWire - BZX
Actavis and Allergan Announce Early Termination of Hart-Scott-Rodino Waiting Period for Actavis' Pending Acquisition of Allergan and Record Dates for Shareholder Meetings 8:00 a.m. Jan. 12, 2015 - PR Newswire - PRF
ALERT: Rosen Law Firm Reminds Investors Who Sold Allergan Inc. Stock of the Important Class Action Deadline -- AGN 11:11 a.m. Jan. 6, 2015 - GlobeNewswire
Law Offices of Howard G. Smith Announces Investigation on Behalf of Investors Who Sold Allergan, Inc. Common Stock Between February 25, 2014 and April 21, 2014 10:32 a.m. Dec. 29, 2014 - BusinessWire - BZX
SHAREHOLDER ALERT: Investors Who Sold Allergan, Inc. Common Stock Between February 25, 2014 and April 21, 2014 Are Encouraged to Contact Glancy Binkow & Goldberg LLP 12:32 p.m. Dec. 23, 2014 - BusinessWire - BZX
AGN SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Involving Allergan, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of February 16, 2015 -- AGN 5:48 p.m. Dec. 18, 2014 - GlobeNewswire
EQUITY ALERT: The Rosen Law Firm Announces the Filing of Securities Class Action on Behalf of Sellers of Allergan Inc. Stock From February 25, 2014 to April 21, 2014 Seeking to Recover Losses -- AGN 3:59 p.m. Dec. 18, 2014 - GlobeNewswire
COTCHETT, PITRE & McCARTHY, LLP Files Class Action Lawsuit on Behalf of Persons Who Sold Allergan Stock Between February 25, 2014 and April 21, 2014 1:47 p.m. Dec. 17, 2014 - BusinessWire - BZX
Deadline in Lawsuit for Certain Sellers of Allergan, Inc. (AGN) Shares Announced by Shareholders Foundation 11:15 a.m. Dec. 17, 2014 - GlobeNewswire
BOTTINI & BOTTINI, INC. Files Class Action Lawsuit On Behalf Of Persons Who Sold Allergan Stock Between February 25, 2014 And April 21, 2014 9:30 a.m. Dec. 17, 2014 - PR Newswire - PRF
Pharma Equities Technical Analysis -- GlaxoSmithKline, Bristol-Myers Squibb, Teva Pharmaceutical Industries, Endo Intl., and Allergan 9:05 a.m. Dec. 17, 2014 - PR Newswire - PRF
Actavis Announces Proposed Senior Leadership Team Effective Following Completion of Allergan Acquisition 7:30 a.m. Dec. 16, 2014 - PR Newswire - PRF
Wilshire Confirms First-to-File Patent Challenge Relating to LASTACAFT® 3:18 p.m. Dec. 11, 2014 - PR Newswire - PRF
(0)
(0)Scroll down for more posts ▼